Conclusion-Alcoholic cirrhotic patients may have enhanced concentrations of ligands for neuronal and peripheral benzodiazepine receptors and these may contribute to cognitive impairments in these patients. (7NeurolNeurosurg Psychiatry 1996;60:676-680) 
and from an uncontrolled trial of flumazenil in patients with latent hepatic encephalopathy. 6 The pattern of psychomotor and memory impairments induced by benzodiazepines in healthy subjects is similar to that in hepatic encephalopathy.7 In a recent double blind placebo controlled study both alcoholic and non-alcoholic cirrhotic patients were significantly impaired in performance of psychomotor tasks. The episodic memory impairment of the alcoholic cirrhotic patients was reversed by flumazenil, which suggests that endogenous benzodiazepine receptor ligands contributed to this impairment.8
The purpose of the present study was to obtain measures of cognitive performance, circulating ligands for the neuronal benzodiazepine receptor, and benzodiazepine binding variables in platelets of alcoholic and nonalcoholic cirrhotic patients and matched controls. Our hypothesis was that the differences in cognitive performance between the groups would be related to differences in the concentrations of circulating ligands, to differences in benzodiazepine binding characteristics, or both, measured in platelets. 
Subjects

BENZODIAZEPINE BINDING IN PLATELETS
The number and affinity of peripheral benzodiazepine receptors were determined in the platelet enriched pellet, after one freeze-thaw and three washes to remove any circulating endogenous ligands. The The cognitive tests were those previously shown to be sensitive to impairments found in alcoholic and non-alcoholic cirrhotic patients.8
The tests were brief and easily given at the bedside. They tapped memory (word recall), reaction times, focused attention (digit cancellation), and visual search/attention/mental flexibility, and motor speed (trails).
Immediate and delayed recall Sixteen bisyllabic nouns were presented via a notebook computer and patients were asked to read the words aloud. Each word was displayed for two seconds and separated from the next word by one second. Patients were asked for spoken recall immediately after the last word was presented, and again after the delay filled by the tests below.
Reaction times
The patient was asked to press the space bar as quickly as possible after the appearance of a "flower" shape on the screen. Twenty four trials were given with random interstimulus intervals. The score is the median delay to pressing the bar.
Digit cancellation
The time taken to score out 40 number 4s randomly interspersed among 400 numbers was recorded.
Trails test This paper and pencil test has two parts, trails A and B, each requiring the patient to complete a trail.'2 Trails A requires the patient to serially connect 25 encircled numbers with a continuous line; trails B requires the alternate connection of 25 encircled numbers and letters (1-A-2-B-3-C-etc).
Statistics
The reaction time, digit cancellation, and peripheral benzodiazepine receptor binding data were analysed with one way analyses of variance (ANOVA) with the subject groups as the independent factor; the recall and trails data were analysed with ANOVAs with time of recall and trails task as the repeated measures and the subject groups as the independent factor. In all cases comparisons between individual groups was made after ANOVA with Duncan's tests (see fig 2) . Spearman's correlation coefficients were calculated to determine the correlations between benzodiazepine receptor affinity and performance in the psychometric tasks. 
Results
LIVER FUNCTION
There were no significant differences between the two patient groups in liver function (table) . The higher INR and bilirubin in the alcoholic group just missed significance (P = 0 10 and P = 0d18 respectively).
ENDOGENOUS LIGANDS
None of the control group had detectable ligands in the serum, but one of the non-alcoholic cirrhotic patients (39 1 nM flumazenil equivalents) and three of the alcoholic patients (8&3, 30 4, 13-4 nM) had measurable concentrations.
BENZODIAZEPINE BINDING IN PLATELETS
There was no detectable platelet binding in four alcoholic and four non-alcoholic cirrhotic patients and these patients also had platelet protein concentrations below the limits of our assay. There was no significant difference between the three groups in the number of receptors (F (2, 15) = 1-6), but there was a significant difference in the receptor affinity (F (2, 15) = 4-4, P < 0-05), with the alcoholic group having a higher affinity than the control group ( fig 1) ; the affinity of the non-alcoholic group (6-2 (SEM 1-5)) did not differ from the controls (5 5 (0 4)).
COGNITIVE AND PSYCHOMOTOR PERFORMANCE
Immediate and delayed recall Both groups of patients showed similar, pronounced impairments on both immediate and delayed word recall compared with controls (F (2, 24) = 8-3, P < 0-005; fig 2) . Forgetting (delayed compared with immediate recall) was similar in all three groups (group x time of recall interaction, F (2, 24) = 0-03).
Reaction times
Both groups of patients showed slower reaction times than controls (F (2, Digit cancellation This task showed very clear differences between groups (F (2, 24) = 9 0, P < 0.001). Whereas the alcoholic cirrhotic patients were severely impaired compared with controls, taking on average 50 seconds longer to complete this task, non-alcoholic patients were not impaired (fig 2) .
Trails test
There was a significant difference between the performance of the groups on the trails tests (F (2, 24) = 5.3, P < 0 01); alcoholic cirrhotic patients showed significant impairments compared with controls, and the non-alcoholic patients showed intermediate levels of performance (fig 2) . Trails B took significantly longer than trails A (P < 0-00001) and the difference in performance of the two tasks was greater for the alcoholic patients (P = 0 06).
Comparison with age graded normative data'3 showed controls performing at normal levels, alcoholic cirrhotic patients performing below the 10th percentile on both trails A and trails B, non-alcoholic cirrhotic patients performing below the 10th percentile on trails A and just above the 25th percentile on trails B. (F (1, 14) = < 1 0 in both cases). However, the groups did differ significantly in the time to complete the digit cancellation task (those with ligands taking 146-5 (SEM 16-O)s and those without 93 (14 7)s; F (1, 14) = 4.9, P < 0O05) and there was a trend for greater impairment in the trails tasks for those with ligands (P = 0 07).
To determine whether there was any relation between the affinity of the benzodiazepine receptor and test performance, Spearman's correlation coefficients were calculated. These were significant only for reaction time and digit cancellation (p = 0-51 in both cases, P < 0 05). Thus the higher the receptor affinity, the longer time taken to complete these tests.
Discussion
Although the two patient groups did not differ significantly in their liver function, this may have been due to the few patients studied. There was a clear trend for greater abnormalities in the alcoholic group and this increased impairment of liver function is likely to have resulted in the higher concentrations of endogenous ligands for the benzodiazepine receptor. These ligands could have originated from the food chain or gut fermentation products and impaired liver function would reduce their metabolic clearance. The cognitive differences between the two groups are likely to result from the CNS effects of alcohol adding to or interacting with the actions of benzodiazepine ligands on the CNS. In terms of cognitive performance, the alcoholic patients showed greater impairments than non-alcoholic patients and controls on the focused attention task (digit cancellation) and the trails tests. A relatively greater impairment in the alcoholic group on trails B compared with trails A emerged as both a nearly significant trend (P = 0 06) and in comparison with normative data, suggesting a level of executive dysfunction. Performance on the digit cancellation and trails tasks was related to the presence of endogenous ligands for the neuronal benzodiazepine receptor. Interestingly, it is also these tasks that are impaired in chronic benzodiazepine users."4 This raises the intriguing possibility that the impairments in attentional or executive function, particularly apparent in the alcoholic cirrhotic patients, might result from raised brain concentrations of benzodiazepine receptor ligands.
There was also a significantly enhanced affinity for the platelet benzodiazepine receptors in the alcoholic group. The receptor affinity correlated significantly with the times taken to complete both reaction time and digit cancellation tasks, suggesting a possible contribution to motor slowing and impaired focused attention. A change in receptor affinity indicates that either some conformational change in the receptor has occurred, or that an endogenous ligand remained tightly attached to the receptor. Gavish and Fares15 found that the process of freezing, thawing, and washing membranes significantly enhanced the affinity of benzodiazepine receptors in the kidney and suggested that this process may have released a tightly bound endogenous ligand. Our binding assay used similar procedures and therefore one possibility is that higher concentrations of such a ligand were present in the alcoholic group. Peripheral benzodiazepine receptors differ in their pharmacological characteristics from the ones found on neurons'6 and the present results suggest that alcoholic cirrhotic patients may have higher concentrations of circulating ligands, some of which are active at neuronal receptors and some of which are active at peripheral ones. Peripheral benzodiazepine receptors are found on various tissues, including the heart, kidney, and adrenals, where they control the rate limiting step in steroid synthesis.'7 If changed affinity occurs in other peripheral tissues, this could contribute to a wide range of physiological symptoms. The peripheral type of benzodiazepine receptors also occur in the brain on glial cells, where they regulate the synthesis of neurosteroids, and an increased affinity has been reported in the brainstem of rats with experimental hepatic encephalopathy.'8 However, it would seem unlikely that affinity changes will be found on all peripheral sites and, indeed, one study of patients with hepatic encephalopathy found no difference in the affinity of benzodiazepine receptors on lymphocytes, although the patients with hepatic encephalopathy had a reduced number of peripheral receptors compared with controls. '9 In conclusion, our results have shown greater cognitive impairments in alcoholic, compared with non-alcoholic, patients with grade-I hepatic encephalopathy and suggest that these impairments may be linked to an increased incidence of endogenous ligands for the benzodiazepine receptor or to changes in receptor binding. Our conclusions have to be viewed with caution because of the small number of patients in which it was possible to measure platelet binding. This was because of the reduction in platelet concentration that is known to occur in hepatic encephalopathy2" and was indicated in our patients by unmeasurable plasma protein concentrations. It is thus likely to be a persisting problem in studying benzodiazepine binding in these patients. However, the small sample sizes are more likely to have obscured differences-for example, in the number of receptors-rather than produced false positives. The potential importance of these findings would certainly seem to warrant a more extensive study with a wider range of cognitive tests. All of our patients were assessed during a period of abstinence and there was no evidence that the extent of the biochemical changes could be linked to the duration of abstinence. Impaired liver function would affect the metabolism of endogenous benzodiazepine ligands and thus it is most likely that the results obtained reflect a combination of the effects of alcohol on the brain and liver disease. 
